About Biobeat
Biobeat® is a bio-medical technology company based in Israel.
Its worldwide patented technology is currently in numerous countries for remote patient monitoring, pulmonology, cardiology, as well as for Covid-19 monitoring.
A new way to look after heart health
Heart disease is the leading cause of death for people in the United States. Today's Challenges in Hypertension Diagnosis include the fact that patients are being diagnosed using a cuff device that was developed 100 years ago. These are uncomfortable and cumbersome devices which many experts claim have limited accuracy as well as fact that measuring Blood Pressure alone does not necessarily provide a full picture. Ambulatory profiles based on these dated legacy technologies are also limited in their diagnostic value because they only trend to blood pressure and heart rate. Missing are underlying components of blood pressure and perfusion, i.e., cardiac output, systemic vascular resistance, stroke volume, and mean arterial pressure.
Biobeat Chest Monitor
- Disposable, short term use product.
- Designed for single patient use to avoid transmission of diseases.
- Separate sticker and sensor capsule for easy removal and replacement.
- Battery life of up to 5 days.
- Biobeat's ABPM technologies is the only FDA-listed cuff-less PPG-based wearable blood pressure sensor that measures blood pressure, heart rate, cardiac output, systemic vascular resistance, stroke volume, and mean arterial pressure.
- The perfect remote monitoring device to support telehealth programs and remote medical services.
- MBE certified diversity supplier, every purchase counts as a tier one diversity purchase.
A New Way to Monitor Blood Pressure
Biobeat's cuffless blood pressure systems integrates a proprietary sensor based on reflective PPG plus its patented hardware are the first revolutionary advancements in blood pressure measurement, diagnostics, and profiling since blood pressure was resolved in 1905.
Biobeat's ABPM technologies is the only FDA-listed cuffless PPG-based wearable blood pressure sensor that measures blood pressure, heart rate, cardiac output, systemic vascular resistance, stroke volume, and mean arterial pressure. Helps determine if provider should treat the heart (change the pulse rate and pressure from the heart if elevated cardiac output), or treat the periphery and reduce the systemic vascular resistance, or treat both.
How it Works
FDA Indications for Use
The Biobeat Platform is a wireless noninvasive remote monitoring system for use by healthcare professionals for spot check collection of physiological data in home and healthcare settings. This can include, functional oxygen saturation of arterial hemoglobin (%SpO2), pulse rate, blood pressure, respiration rate (RRp), and body temperature.
The Biobeat Platform tracks changes in blood pressure based on Pulse Wave Transit Time (PWTT) which is obtained utilizing pulse measurements from the integrated SpO2 sensor, following a calibration process using an FDA-cleared oscillometric blood pressure monitor.
The Biobeat Platform is intended for spot-checking and tracking changes of adult patients in hospitals, clinics, long-term care, and at home. The data from the Biobeat Platform are intended for use by healthcare professionals as an aid to diagnosis and treatment. The device is not intended for use on critical care patients.
Biobeat is only sold to healthcare providers and made available to patients from a licensed medical professional. The Biobeat device is not to be used alone or without the direct and continuous close consultation and expert advice of a trained and actively practicing medical professional.
Already In Use
Tampa General Hospital has already made the corporate decision to use this product as a key element of its telehealth services to patients, launching their hospital at-home program
How to Order
HPC is a certified distributer of Biobeat. You can order by contacting us at info@hpcinternationalinc.com or calling (219) 922-4868.
HPC is the partner that companies and healthcare organizations turn to for solutions that reduce operational spending, improve corporate efficiency, and increase access to education and medical research.
